BCM
JSPRW icon

Basso Capital Management’s Japer Therapeutics Warrants JSPRW Stock Holding History

Basso Capital Management’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-18,245
Closed -$26K – 389
2020
Q4 		$26K Sell
18,245
-40,900
-69% -$51.3K 0.01% 183
2020
Q3 		$70K Buy
59,145
+33,306
+129% +$33.7K 0.02% 124
2020
Q2 		$26K Sell
25,839
-9,313
-26% -$5.8K 0.01% 166
2020
Q1 		$23K Buy
+35,152
New +$27.6K 0.01% 190

Other funds holding JSPRW

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

Basso Capital Management's JSPRW Position: Q1 2021 in Review

Basso Capital Management sold out of Japer Therapeutics Warrants (JSPRW) in Q1 2021, closing a stake of 18,245 shares — an estimated $26K sold.

Basso Capital Management first reported a position in JSPRW in Q1 2020 and held it in 4 quarters. The position peaked at $70K in Q3 2020. 26 funds tracked by Wall St. Rank hold JSPRW as of Q1 2021.

  • Basso Capital Management reported no remaining Japer Therapeutics Warrants position as of Q1 2021 after selling out during the quarter.
  • Basso Capital Management sold 18,245 Japer Therapeutics Warrants shares in Q1 2021, an estimated $26K.
  • Basso Capital Management first reported a position in Japer Therapeutics Warrants in Q1 2020 and held it in 4 quarters.
  • Basso Capital Management's Japer Therapeutics Warrants position peaked at $70K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2021.

Based on Basso Capital Management's 13F filing for Q1 2021, filed 10 May 2021.